Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001034061 | SCV001197386 | likely benign | 46,XY sex reversal 6 | 2022-10-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002552440 | SCV003573178 | uncertain significance | Inborn genetic diseases | 2021-08-09 | criteria provided, single submitter | clinical testing | The c.2696A>G (p.N899S) alteration is located in exon 14 (coding exon 14) of the MAP3K1 gene. This alteration results from a A to G substitution at nucleotide position 2696, causing the asparagine (N) at amino acid position 899 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |